Medios AG: Chief Executive Officer Manfred Schneider resigns from the Company's Executive Board as scheduled - Chief Financial Officer Matthias Gärtner to become the new Chief Executive Officer with early extension of his term of office

Medios AG / Key word(s): Personnel
Medios AG: Chief Executive Officer Manfred Schneider resigns from the Company's Executive Board as scheduled - Chief Financial Officer Matthias Gärtner to become the new Chief Executive Officer with early extension of his term of office

21-Oct-2020 / 18:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Medios AG: Chief Executive Officer Manfred Schneider resigns from the Company's Executive Board as scheduled - Chief Financial Officer Matthias Gärtner to become the new Chief Executive Officer with early extension of his term of office

Berlin, 21 October 2020 - The Chairman of the Executive Board of Medios AG, Manfred Schneider, today informed the Supervisory Board that he will not extend his contract, which expires on 31 December 2020, for family reasons and will leave the Executive Board at that date. The Supervisory Board deeply regrets that Manfred Schneider is not available for another term of office and expresses its respect and high appreciation for his successful work.

As founder and major shareholder of the Company, Manfred Schneider will remain closely associated with Medios AG and is to become a key member of a new Advisory Board to be established for the Company. In addition, Manfred Schneider has agreed to a voluntary 6-month lock-up agreement for the major part of his Medios shares. In order to maintain continuity in the Company's development, the Supervisory Board has decided to appoint Matthias Gärtner, Chief Financial Officer of Medios AG, as Chief Executive Officer of the Company as of 1 January 2021. In addition, the Supervisory Board intends to extend Matthias Gärtner's Executive Board contract prematurely by two years to 30 June 2023 soon.

The Supervisory Board does not consider any further changes in the Executive Board to be necessary, since the contracts of the other members of the Executive Board run until 30 June 2022 (Mi-Young Miehler) and 31 December 2023 (Christoph Prußeit) and the successful work of the entire Executive Board can thus be continued.

Notifying person: Matthias Gärtner, Chief Financial Officer (CFO) of Medios AG

Contact
Medios AG, Heidestraße 9, 10557 Berlin, Germany
Phone: +49 30 232 5668 00; Fax: +49 30 232 5668 01
E-mail: ir@medios.ag; www.medios.ag

About Medios AG
Medios AG is one of the leading Specialty Pharma companies in Germany. As a specialist for the provision of Specialty Pharma drugs to patients, GMP-certified provider of patient-specific therapies and innovative analytical methods, Medios covers substantial elements of the supply chain in this field and follows the highest international quality standards. Usually, Specialty Pharma drugs are high-priced medicines for rare and/or chronic diseases. Patient-specific therapies are, for example, infusions that are compiled and produced on the basis of individual diseases and parameters like body weight and surface. In the field of drug safety, NIR spectroscopic analysis methods (NIR: Near infrared) are used to distinguish marketable finished drugs from drug counterfeits. It is Medios' aim to provide integrated solutions along the value chain to partners and clients, thereby ensuring an optimal pharmaceutical care for patients.

Medios AG is Germany's first publicly listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8, DE000A288821) are listed in the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).

Contact
Medios AG
Claudia Nickolaus
Head of Investor & Public Relations
Heidestraße 9
10557 Berlin
Germany
Phone: +49 30 232566800
Fax: +49 30 232566801
E-mail: c.nickolaus@medios.ag
www.medios.ag

Disclaimer
This release is a mandatory announcement pursuant to Art. 17 of the Market Abuse Regulation (MAR). The assessments contained therein are, as always, subject to the disclaimer provided below.

Cautionary note regarding forward-looking statements/No duty to update
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.

21-Oct-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de